Randomized Controlled Trial of Social Media: Effect of Increased Intensity of the Intervention von Fox, Caroline S., Gurary, Ellen B., Ryan, John, Bonaca, Marc, Barry, Karen, Loscalzo, Joseph, Massaro, Joseph

Volltext

Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib von Kudo, Masatoshi, Finn, Richard S., Edeline, Julien, Cattan, Stéphane, Ogasawara, Sadahisa, Palmer, Daniel H., Verslype, Chris, Zagonel, Vittorina, Fartoux, Laetitia, Vogel, Arndt, Sarker, Debashis, Verset, Gontran, Chan, Stephen L., Knox, Jennifer, Daniele, Bruno, Yau, Thomas, Gurary, Ellen B., Siegel, Abby B., Wang, Anran, Cheng, Ann-Lii, Zhu, Andrew X.

Volltext

Parental non‐alcoholic fatty liver disease increases risk of non‐alcoholic fatty liver disease in offspring von Long, Michelle T., Gurary, Ellen B., Massaro, Joseph M., Ma, Jiantao, Hoffmann, Udo, Chung, Raymond T., Benjamin, Emelia J., Loomba, Rohit

Volltext

Olaparib with or without bevacizumab or bevacizumab and 5-fluorouracil in advanced colorectal cancer: Phase III LYNK-003 von Kim, Tae Won, Taieb, Julien, Gurary, Ellen B, Lerman, Nati, Cui, Karen, Yoshino, Takayuki

Volltext

Stage II Oral Tongue Cancer: Survival Impact of Adjuvant Radiation Based on Depth of Invasion von Rubin, Samuel J., Gurary, Ellen B., Qureshi, Muhammad M., Salama, Andrew R., Ezzat, Waleed H., Jalisi, Scharukh, Truong, Minh Tam

Volltext

Effect of smoking and soft tissue release on risk of revision after total knee arthroplasty: a case- control study von Nwachukwu, Benedict U, Gurary, Ellen B, Lerner, Vladislav, Collins, Jamie E, Thornhill, Thomas S, Losina, Elena, Katz, Jeffrey N

Volltext

Olaparib ± bevacizumab versus bevacizumab + fluorouracil in patients with unresectable or metastatic colorectal cancer not progressing on first-line FOLFOX + bevacizumab: Phase III... von Mayo, Carlos Alberto, Gurary, Ellen B., Marinello, Patricia

Volltext

328 Phase 3 study of olaparib ± bevacizumab versus bevacizumab + fluorouracil in patients with unresectable or metastatic colorectal cancer not progressing on first-line FOLFOX + b... von Mayo, Carlos, Gurary, Ellen B, Marinello, Patricia

Volltext

Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib von Kudo, Masatoshi, Finn, Richard S, Edeline, Julien, Cattan, Stephane, Ogasawara, Sadahisa, Palmer, Daniel H, Verslype, Chris, Zagonel, Vittorina, Fartoux, Laetitia, Vogel, Arndt, Sarker, Debashis, Verset, Gontran, Chan, Stephen L, Knox, Jennifer, Daniele, Bruno, Yau, Thomas, Gurary, Ellen B, Siegel, Abby B, Wang, Anran, Cheng, Ann-Lii, Zhu, Andrew X

Volltext

Updated efficacy and safety of KEYNOTE-224: A phase II study of pembrolizumab (pembro) in patients with advanced hepatocellular carcinoma (HCC) von Kudo, Masatoshi, Finn, Richard S., Edeline, Julien, Cattan, Stéphane, Ogasawara, Sadahisa, Palmer, Daniel H., Verslype, Chris, Zagonel, Vittorina, Fartoux, Laetitia, Vogel, Arndt, Sarker, Debashis, Verset, Gontran, Chan, Stephen Lam, Knox, Jennifer J., Daniele, Bruno, Gurary, Ellen B, Siegel, Abby B., Jain, Lokesh, Cheng, Ann-Lii, Zhu, Andrew X.

Volltext

Effect of smoking and soft tissue release on risk of revision after total knee arthroplasty: a case- control study von Nwachukwu, Benedict, Gurary, Ellen B, Lerner, Vladislav, Collins, Jamie E, Thornhill, Thomas Stone, Losina, Elena, Katz, Jeffrey Neil

Volltext

Randomized Controlled Trial of Social Media: Effect of Increased Intensity of the Intervention von Fox, Caroline S, Gurary, Ellen B, Ryan, John, Bonaca, Marc, Barry, Karen, Loscalzo, Joseph, Massaro, Joseph

Volltext

ENP-8. KEYLYNK-012 : Pembrolizumab+CCRT Then Pembrolizumab±Olaparib vs CCRT Then Durvalumab in NSCLC von Terufumi Kato, Salma K. Jabbour, Byoung Chul Cho, Emilio Bria, Jaishree Bhosle, Justin F. Gainor, Noemi Reguart, Luhua Wang, Daniel Morgensztern, Ellen B. Gurary, Tanya B. Ashraf, Humberto Lara-Guerra, Martin Reck

Volltext

FON-2021-0899 Infographic – Olaparib with or without bevacizumab or bevacizumab and 5-fluorouracil in advanced colorectal cancer: Phase III LYNK-003 von Kim, Tae Won, Taieb, Julien, Gurary, Ellen B, Lerman, Nati, Cui, Karen, Yoshino, Takayuki

Volltext bestellen

Phase 3 study of pembrolizumab with concurrent chemoradiation therapy followed by pembrolizumab with or without olaparib versus concurrent chemoradiation therapy followed by durval... von Jabbour, Salma K., Cho, Byoung Chul, Bria, Emilio, Kato, Terufumi, Bhosle, Jaishree, Gainor, Justin F., Reguart, Noemi, Wang, Luhua, Morgensztern, Daniel, Gurary, Ellen, Ashraf, Tanya B., Lara-Guerra, Humberto, Reck, Martin

Volltext